Iron, anemia and erythrocytosis in pregnant women at highlands: risks in mothers and newborns

Descripción del Articulo

Iron is essential for health but in excess may be harmful. The living organism has ability to store and re-use the iron body and as such its requirement is small (1-2 mg absorbed/day). Hepcidin, a hormone produced in the liver, has an important role in iron homeostasis by blocking the iron transport...

Descripción completa

Detalles Bibliográficos
Autores: Gonzales, Gustavo F., Gonzales, Carla
Formato: artículo
Fecha de Publicación:2013
Institución:Sociedad Peruana de Obstetricia y Ginecología
Repositorio:Revista Peruana de Ginecología y Obstetricia
Lenguaje:español
OAI Identifier:oai:ojs.pkp.sfu.ca:article/50
Enlace del recurso:http://51.222.106.123/index.php/RPGO/article/view/50
Nivel de acceso:acceso abierto
id REVSPOG_b7d0b480dbc450f8d0e75bf4ea3a10d8
oai_identifier_str oai:ojs.pkp.sfu.ca:article/50
network_acronym_str REVSPOG
network_name_str Revista Peruana de Ginecología y Obstetricia
repository_id_str .
dc.title.none.fl_str_mv Iron, anemia and erythrocytosis in pregnant women at highlands: risks in mothers and newborns
Hierro, anemia y eritrocitosis en gestantes de la altura: riesgo en la madre y el recién nacido
title Iron, anemia and erythrocytosis in pregnant women at highlands: risks in mothers and newborns
spellingShingle Iron, anemia and erythrocytosis in pregnant women at highlands: risks in mothers and newborns
Gonzales, Gustavo F.
title_short Iron, anemia and erythrocytosis in pregnant women at highlands: risks in mothers and newborns
title_full Iron, anemia and erythrocytosis in pregnant women at highlands: risks in mothers and newborns
title_fullStr Iron, anemia and erythrocytosis in pregnant women at highlands: risks in mothers and newborns
title_full_unstemmed Iron, anemia and erythrocytosis in pregnant women at highlands: risks in mothers and newborns
title_sort Iron, anemia and erythrocytosis in pregnant women at highlands: risks in mothers and newborns
dc.creator.none.fl_str_mv Gonzales, Gustavo F.
Gonzales, Carla
author Gonzales, Gustavo F.
author_facet Gonzales, Gustavo F.
Gonzales, Carla
author_role author
author2 Gonzales, Carla
author2_role author
description Iron is essential for health but in excess may be harmful. The living organism has ability to store and re-use the iron body and as such its requirement is small (1-2 mg absorbed/day). Hepcidin, a hormone produced in the liver, has an important role in iron homeostasis by blocking the iron transport protein and inhibiting iron absorption. Maternal anemia due to iron deficiency is a public health problem when it is moderate (7-<9 g/dL) and severe (Hb<7 g/dL) since it increases the risk of maternal and neonatal morbi-mortality. Similarly, high levels of hemoglobin during pregnancy affect the mother and newborn. In Peru, there is a National Program to supplement with iron to all pregnant women anemic or not. Scientific evidence shows that hemoglobin values between 9-10.5 g/dL are optimal for best fetal growth and that treatment with iron supplementation to non anemic women increases levels of hemoglobin, oxidative stress, and has adverse effects on the newborn. Since many populations at highlands have increased hemoglobin levels, it has been suggested to correct hemoglobin cutoff to define anemia. Several studies have demonstrated that it would not be necessary to change this cut-off as defined for population at sea level. In conclusion, studies results do not support the need for generalized iron supplementation to all pregnant women. Iron supplementation to pregnant women at high altitude should be avoided if diagnosis of anemia is not clearly demonstrated. It is recommended for each altitudinal population determining the level of anemia and body iron status before deciding to treat with iron supplements.Key words: Maternal anemia, maternal erythrocytosis, hepcidin, altitude, iron.
publishDate 2013
dc.date.none.fl_str_mv 2013-10-24
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://51.222.106.123/index.php/RPGO/article/view/50
url http://51.222.106.123/index.php/RPGO/article/view/50
dc.language.none.fl_str_mv spa
language spa
dc.relation.none.fl_str_mv http://51.222.106.123/index.php/RPGO/article/view/50/44
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Sociedad Peruana de Obstetricia y Ginecología
publisher.none.fl_str_mv Sociedad Peruana de Obstetricia y Ginecología
dc.source.none.fl_str_mv The Peruvian Journal of Gynecology and Obstetrics ; Vol. 58 No. 4 (2012); 329-340
Revista Peruana de Ginecología y Obstetricia; Vol. 58 Núm. 4 (2012); 329-340
2304-5132
2304-5124
reponame:Revista Peruana de Ginecología y Obstetricia
instname:Sociedad Peruana de Obstetricia y Ginecología
instacron:SPOG
instname_str Sociedad Peruana de Obstetricia y Ginecología
instacron_str SPOG
institution SPOG
reponame_str Revista Peruana de Ginecología y Obstetricia
collection Revista Peruana de Ginecología y Obstetricia
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1845248485959401472
spelling Iron, anemia and erythrocytosis in pregnant women at highlands: risks in mothers and newbornsHierro, anemia y eritrocitosis en gestantes de la altura: riesgo en la madre y el recién nacidoGonzales, Gustavo F.Gonzales, CarlaIron is essential for health but in excess may be harmful. The living organism has ability to store and re-use the iron body and as such its requirement is small (1-2 mg absorbed/day). Hepcidin, a hormone produced in the liver, has an important role in iron homeostasis by blocking the iron transport protein and inhibiting iron absorption. Maternal anemia due to iron deficiency is a public health problem when it is moderate (7-<9 g/dL) and severe (Hb<7 g/dL) since it increases the risk of maternal and neonatal morbi-mortality. Similarly, high levels of hemoglobin during pregnancy affect the mother and newborn. In Peru, there is a National Program to supplement with iron to all pregnant women anemic or not. Scientific evidence shows that hemoglobin values between 9-10.5 g/dL are optimal for best fetal growth and that treatment with iron supplementation to non anemic women increases levels of hemoglobin, oxidative stress, and has adverse effects on the newborn. Since many populations at highlands have increased hemoglobin levels, it has been suggested to correct hemoglobin cutoff to define anemia. Several studies have demonstrated that it would not be necessary to change this cut-off as defined for population at sea level. In conclusion, studies results do not support the need for generalized iron supplementation to all pregnant women. Iron supplementation to pregnant women at high altitude should be avoided if diagnosis of anemia is not clearly demonstrated. It is recommended for each altitudinal population determining the level of anemia and body iron status before deciding to treat with iron supplements.Key words: Maternal anemia, maternal erythrocytosis, hepcidin, altitude, iron.El hierro es un micronutriente necesario para la salud, pero su exceso es dañino. El organismo tiene una alta capacidad de almacenar y reutilizar el hierro corporal, de tal manera que su requerimiento es mínimo (1 a 2 mg absorbido/día). La hepcidina, una hormona producida en el hígado, cumple un rol importante en la homeostasis del hierro inhibiendo a la proteína transportadora de hierro y disminuyendo la absorción de hierro. La anemia materna por deficiencia de hierro se constituye en un problema de salud pública cuando es de magnitud moderada (7 a <9 g/dL) y severa (Hb <7 g/dL), incrementando el riesgo de morbi-mortalidad materna y del neonato. Igualmente, se ha demostrado que niveles altos de hemoglobina en la gestante afecta a la madre y al neonato. En el Perú existe el Programa Nacional de Suplemento con hierro a todas las gestantes, sean o no anémicas. Las evidencias científicas muestran que valores de hemoglobina entre 9 y 10,5 g/dL son óptimas para el mejor crecimiento del feto y que el tratamiento con suplemento de hierro de gestantes no anémicas aumenta los niveles de hemoglobina, el estrés oxidativo y tiene efectos adversos en el recién nacido. Dado que en muchas poblaciones en la altura aumentan los niveles de hemoglobina, se ha sugerido corregir el punto de corte de la Hb para definir anemia. Diversos estudios han mostrado que no sería necesario corregir el punto de corte usado a nivel del mar. En conclusión, los resultados de los estudios no apoyan la necesidad de un suplemento de hierro de forma generalizada a toda gestante. La suplementación con hierro a las gestantes en la altura debería ser evitada si es que la anemia no está claramente demostrada. Se recomienda en cada población de altitud establecer el nivel de anemia y el estatus del hierro corporal, antes de decidir dar un tratamiento con suplemento de hierro.Palabras clave: Anemia materna, eritrocitosis materna, hepcidina, altura, hierro.Sociedad Peruana de Obstetricia y Ginecología2013-10-24info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttp://51.222.106.123/index.php/RPGO/article/view/50The Peruvian Journal of Gynecology and Obstetrics ; Vol. 58 No. 4 (2012); 329-340Revista Peruana de Ginecología y Obstetricia; Vol. 58 Núm. 4 (2012); 329-3402304-51322304-5124reponame:Revista Peruana de Ginecología y Obstetriciainstname:Sociedad Peruana de Obstetricia y Ginecologíainstacron:SPOGspahttp://51.222.106.123/index.php/RPGO/article/view/50/44info:eu-repo/semantics/openAccessoai:ojs.pkp.sfu.ca:article/502013-10-28T01:35:03Z
score 13.277489
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).